Koers Cytosorbents Corp OTC Bulletin Board
Aandelen
CTSO
US23283X1072
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 39,52 mln. 36,42 mln. | Omzet 2025 * | 46,83 mln. 43,16 mln. | Marktkapitalisatie | 48,88 mln. 45,04 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -20 mln. -18,43 mln. | Nettowinst (verlies) 2025 * | -9 mln. -8,29 mln. | EV/omzet 2024 * | 1,24 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 1,04 x |
K/w-verhouding 2024 * |
-2,35
x | K/w-verhouding 2025 * |
-4,79
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 96,8% |
Recentste transcriptie over Cytosorbents Corp
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Phillip Chan
CEO | Chief Executive Officer | 53 | 24-07-08 |
Vincent Capponi
PSD | President | 66 | 25-04-02 |
Kathleen Bloch
DFI | Director of Finance/CFO | 69 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Bator
CHM | Chairman | 60 | 14-07-15 |
Phillip Chan
CEO | Chief Executive Officer | 53 | 24-07-08 |
Edward Jones
BRD | Director/Board Member | 75 | 01-04-07 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,87% | 223 mld. | |
+11,83% | 195 mld. | |
+18,87% | 144 mld. | |
+30,03% | 111 mld. | |
+2,32% | 65,19 mld. | |
+14,15% | 53,02 mld. | |
+2,68% | 50,28 mld. | |
+6,60% | 44,15 mld. | |
+1,85% | 36,45 mld. |